0 205

Cited 1 times in

Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B-authors' reply

DC Field Value Language
dc.contributor.author김승업-
dc.date.accessioned2022-09-02T01:09:17Z-
dc.date.available2022-09-02T01:09:17Z-
dc.date.issued2020-09-
dc.identifier.issn0269-2813-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/190009-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherWiley-Blackwell-
dc.relation.isPartOfALIMENTARY PHARMACOLOGY & THERAPEUTICS-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHCarcinoma, Hepatocellular* / epidemiology-
dc.subject.MESHCarcinoma, Hepatocellular* / etiology-
dc.subject.MESHHepatitis B e Antigens-
dc.subject.MESHHepatitis B virus-
dc.subject.MESHHepatitis B, Chronic* / complications-
dc.subject.MESHHepatitis B, Chronic* / epidemiology-
dc.subject.MESHHumans-
dc.subject.MESHLiver Neoplasms* / epidemiology-
dc.subject.MESHLiver Neoplasms* / etiology-
dc.titleLetter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B-authors' reply-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorHan Ah Lee-
dc.contributor.googleauthorSeung Up Kim-
dc.identifier.doi10.1111/apt.15992-
dc.contributor.localIdA00654-
dc.relation.journalcodeJ00061-
dc.identifier.eissn1365-2036-
dc.identifier.pmid32852833-
dc.identifier.urlhttps://onlinelibrary.wiley.com/doi/full/10.1111/apt.15992-
dc.contributor.alternativeNameKim, Seung Up-
dc.contributor.affiliatedAuthor김승업-
dc.citation.volume52-
dc.citation.number5-
dc.citation.startPage913-
dc.citation.endPage914-
dc.identifier.bibliographicCitationALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.52(5) : 913-914, 2020-09-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.